DrugCard
DrugCard is your trusted partner in local literature screening for the pharmaceutical industry. This cutting-edge AI tool is tailored to streamline drug safety routines, ensuring compliance with regulatory demands while providing transparency and traceability.
Key Features and Capabilities:
Continuous Screening: Stay up-to-date with the latest local literature in your pharmaceutical markets with regular, automated screening.
Transparency: Track and monitor the screening process for accuracy, completeness, and holistic coverage.
Scalability: Expand your pharmaceutical operations globally with DrugCard's support for new markets, multiple languages, and suppliers.
Cost-Effective: Achieve cost savings by avoiding heavy capital investments, making DrugCard an efficient choice for pharma companies.
Global Coverage: Access medical journals from over 35 countries in more than 100 languages, ensuring comprehensive screening.
User-Friendly: Tailored for various pharmaceutical users, including Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers.
User Benefits:
Summary:
DrugCard is the go-to solution for local literature screening in the pharmaceutical industry. Offering continuous screening, transparency, scalability, and cost-effectiveness, it empowers pharmaceutical companies, CROs, MAHs, and freelancers to streamline drug safety processes, meet regulatory requirements, and ensure compliance with confidence.
DrugCard is your trusted partner in local literature screening for the pharmaceutical industry. This cutting-edge AI tool is tailored to streamline drug safety routines, ensuring compliance with regulatory demands while providing transparency and traceability.
Key Features and Capabilities:
Continuous Screening: Stay up-to-date with the latest local literature in your pharmaceutical markets with regular, automated screening.
Transparency: Track and monitor the screening process for accuracy, completeness, and holistic coverage.
Scalability: Expand your pharmaceutical operations globally with DrugCard's support for new markets, multiple languages, and suppliers.
Cost-Effective: Achieve cost savings by avoiding heavy capital investments, making DrugCard an efficient choice for pharma companies.
Global Coverage: Access medical journals from over 35 countries in more than 100 languages, ensuring comprehensive screening.
User-Friendly: Tailored for various pharmaceutical users, including Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers.
User Benefits:
Summary:
DrugCard is the go-to solution for local literature screening in the pharmaceutical industry. Offering continuous screening, transparency, scalability, and cost-effectiveness, it empowers pharmaceutical companies, CROs, MAHs, and freelancers to streamline drug safety processes, meet regulatory requirements, and ensure compliance with confidence.
Pricing model: